Syncrodin Tablets

Directions

Please refer to the medication’s patient information leaflet before starting any new medication.

• Take one tablet daily, 1 to 2 hours before bedtime

• Swallow whole with water—do not crush or chew

• Maintain consistent bedtime routine
  Storage instructions:

• Store below 25°C

• Keep in original packaging

• Keep out of reach of children

Ingredients

Active Ingredient:

• Melatonin 2mg (prolonged-release)

Other Ingredients:

• Calcium hydrogen phosphate

• Hypromellose

• Povidone

• Magnesium stearate

• Silica colloidal

• Titanium dioxide

• Macrogol

Side Effects

Common side effects may include:

• Headache

• Drowsiness

• Nausea

Serious (rare) side effects:

• Mood changes

• Skin rash

• Vision disturbances

Stop the medicine and seek medical attention if serious side effects occur.

Warnings

Do not take Syncrodin if allergic to melatonin or any tablet ingredient. Not suitable for individuals with autoimmune diseases or liver impairment. Use with caution if taking CNS depressants. Avoid alcohol, driving, or operating machinery after taking the tablet. Not intended for patients under 55 years old.

Syncrodin Tablets are a prescription medication used for the short-term treatment of primary insomnia in adults aged 55 years and older. It is particularly effective in patients who experience poor sleep quality and difficulty initiating or maintaining sleep due to age-related melatonin deficiency.

How It Works

Syncrodin contains 2mg of melatonin in a prolonged-release formulation. Melatonin is a hormone naturally produced by the brain in response to darkness. It plays a key role in regulating the circadian rhythm and promoting restful sleep. Syncrodin helps restore the body’s natural melatonin levels, making it easier to fall asleep and remain asleep throughout the night.

Why Choose Syncrodin Tablets

Syncrodin is a well-tolerated, non-sedative treatment option that aligns with the body’s natural biological rhythms. It supports a healthy sleep-wake cycle without causing morning grogginess or dependence. Its prolonged-release design ensures melatonin is released gradually throughout the night, improving sleep continuity in older adults who may struggle with frequent awakenings or early morning waking.

Important Note

Syncrodin is not a general-purpose sleeping pill and should be used only under medical supervision. It is not recommended for individuals under 55 years of age or those with autoimmune disorders. Avoid alcohol during treatment, as it can interfere with the effectiveness of melatonin. If symptoms persist after 13 weeks of treatment, reassessment by a healthcare provider is advised.